Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSeung-Jung Park
About this trial
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
coronary disease amenable to percutaneous coronary intervention (PCI)
no clinical and lesion limitations
Disqualifiers
patients with a mixture of several drug eluting stents
terminal illness with life expectancy less than 1 year
patients with cardiogenic shock
Trial population
consecutive patients amenable to percutaneous coronary intervention with drug eluting stents
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
50,000 Participants
are grouped into 1 trial groupGroup A: Drug eluting stent
Trial outcomes
Primary outcomes
1
Major Adverse Cardiac Event
Death from any causes, myocardial infarction or any repeat revascularization
Time frame
1yearSecondary outcomes
1
all cause Death
Time frame
1year2
Myocardial Infarction
Time frame
1year3
The composite of Death or myocardial infarction
Time frame
1year4
Any repeat revascularization
Time frame
1yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
Source ClinicalTrials.gov